Zevra Therapeutics Inc. (ZVRA)
7.67
0.35 (4.78%)
At close: Apr 02, 2025, 3:59 PM
7.48
-2.54%
After-hours: Apr 02, 2025, 07:34 PM EDT
Zevra Therapeutics Balance Sheet Statement
Financials in USD. Fiscal year
is
January - December.
| Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 |
| Cash & Equivalents | 33.78M | 43.05M | 65.47M | 112.35M | 4.21M | 3.22M | 18.41M | 10.87M | 16.76M | 32.32M | 10.26M | 1.97M | 2.54M |
| Short-Term Investments | 35.71M | 24.69M | 17.38M | n/a | n/a | n/a | 3.26M | 31.36M | 51M | 19M | n/a | n/a | n/a |
| Long-Term Investments | 6.01M | n/a | 20M | 15.42M | n/a | 338K | 710K | 3.25M | 8.2M | n/a | n/a | n/a | n/a |
| Other Long-Term Assets | 11.38M | 9.94M | 724K | 438K | 438K | 527K | 562K | 206K | 360K | 1.24M | 3.08M | 9.18K | -319.45K |
| Receivables | 10.51M | 17.38M | 7.18M | 1.53M | 2.58M | 1.86M | 140K | 2.08M | 5M | 2.38M | n/a | 20.43K | 27.57K |
| Inventory | 1.97M | 24.08M | n/a | 1.00 | 109K | n/a | 224K | 1.00 | 1.1M | -2.38M | n/a | n/a | n/a |
| Other Current Assets | 3.02M | 1.26M | 1.11M | 252K | 203K | 1.37M | n/a | 1.38M | 1.16M | 93K | 178.00 | 50.54K | 34.1K |
| Total Current Assets | 86.03M | 86.94M | 93.02M | 115.06M | 8.38M | 6.63M | 23.72M | 47M | 74.36M | 54.08M | 10.28M | 2.04M | 2.61M |
| Property-Plant & Equipment | 1.01M | 1.53M | 1.78M | 2.02M | 2.39M | 3.01M | 1.75M | 2M | 1.97M | 403K | 352.19K | 380.2K | 319.45K |
| Goodwill & Intangibles | 73.69M | 73.93M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 92.1M | 85.39M | 22.51M | 17.89M | 2.83M | 3.87M | 3.02M | 5.46M | 10.53M | 1.65M | 3.44M | 389.38K | 319.45K |
| Total Assets | 178.13M | 172.33M | 115.53M | 132.94M | 11.21M | 10.51M | 26.75M | 52.46M | 84.89M | 55.72M | 13.71M | 2.43M | 2.93M |
| Account Payables | 13.07M | 13.99M | 3.61M | 516K | 1.17M | 1.14M | 3.71M | 2.18M | 469K | 1.25M | 1.58M | 386.07K | n/a |
| Deferred Revenue | n/a | n/a | 4.66M | 2.52M | 5.47M | 3.77M | 4.63M | 5.7M | 5.97M | n/a | n/a | n/a | n/a |
| Short-Term Debt | 420K | 37.7M | 891K | n/a | 390K | n/a | 3.33M | 3.33M | n/a | 3.41M | 807K | 3.85M | n/a |
| Other Current Liabilities | 8.19M | 10.82M | 1.6M | 2.29M | n/a | 4.01M | 115K | 112K | 41K | n/a | -438 | n/a | 1.05M |
| Total Current Liabilities | 34.06M | 73.72M | 11.73M | 4.23M | 7.54M | 5.43M | 12M | 11.51M | 6.64M | 8.34M | 3.93M | 5.24M | 1.13M |
| Long-Term Debt | 59.88M | 5.07M | 12.8M | n/a | 68.05M | 77.34M | 78.11M | 89.4M | 91.17M | 18.53M | 18.09M | 34.84K | 39.36K |
| Other Long-Term Liabilities | 44.52M | 31.22M | 14.55M | 355K | 427K | 120K | 2.81M | 8.5M | 5.11M | 37.84M | 15.97M | 21.36M | n/a |
| Total Long-Term Liabilities | 104.4M | 36.74M | 18M | 1.59M | 70.08M | 79.53M | 81.31M | 98.46M | 96.94M | 57.5M | 34.08M | 21.45M | 39.36K |
| Total Liabilities | 138.46M | 110.46M | 29.72M | 5.82M | 77.62M | 84.96M | 93.31M | 109.97M | 103.58M | 65.84M | 38.02M | 26.7M | 3.56M |
| Total Debt | 60.3M | 43.77M | 14.12M | 1.59M | 70.35M | 79.53M | 82.05M | 93.48M | 91.33M | 23.1M | 18.15M | 3.97M | n/a |
| Common Stock | 5K | 4K | 3K | 4K | n/a | 4K | 3K | 1K | 1K | 1K | n/a | 1.44M | 1.3M |
| Retained Earnings | -505.29M | -399.78M | -308.57M | -267.03M | -258.47M | -245.71M | -221.19M | -164.73M | -121.34M | -104.82M | -50.16M | -25.71M | -20.48M |
| Comprehensive Income | 631K | -43K | 113K | -0.00 | -0.00 | n/a | n/a | n/a | n/a | n/a | -0.00 | -20.39M | n/a |
| Shareholders Equity | 39.67M | 61.86M | 85.81M | 127.12M | -66.41M | -74.46M | -66.57M | -57.52M | -18.7M | -10.12M | -24.3M | -24.27M | -627.22K |
| Total Investments | 41.72M | 24.69M | 37.38M | 15.42M | n/a | 338K | 3.26M | 34.61M | 59.2M | 19M | n/a | n/a | n/a |